The Baker Institute is committed to scientific excellence and our 2023 Best of Baker Awards recognise outstanding research achievement based on scientific publications. They demonstrate areas where scientific discoveries are likely to have significant impact in health and medical research.
Our focus now is on translating this research to develop new drugs and devices, to inform policy, to develop best-practice prevention and treatment guidelines, and to facilitate education programs for healthcare professionals.
This is how our research is making a difference to the health of Australians, and people around the world.
Winners
- Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts (Basic Science)
- Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA Randomized Clinical Trial (Clinical/Epidemiology)
- A high-salt diet promotes atherosclerosis by altering haematopoiesis (Review)
Runners up
- A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein (Basic Science)
- Poor sleep and shift work associate with increased blood pressure and inflammation in UK Biobank participants (Clinical/Epidemiology)
Other awardees
- Studying the synergistic effect of substrate stiffness and cyclic stretch level on endothelial cells using an elastomeric cell culture chamber (Basic Science)
- Estrogen receptor alpha deficiency in cardiomyocytes reprograms the heart-derived extracellular vesicle proteome and induces obesity in female mice (Basic Science)
- Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice (Basic Science)
- Activated coagulation FXII: a unique target for in vivo molecular imaging (Basic Science)
- New-onset atrial fibrillation prediction: the HARMS2-AF risk score (Clinical/Epidemiology)
- Impact of early versus delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences (Clinical/Epidemiology)
- Childhood non-HDL cholesterol and LDL cholesterol and adult atherosclerotic cardiovascular events (Clinical/Epidemiology)
- Exercise for the prevention of anthracycline-induced functional disability and cardiac dysfunction: the BREXIT Study (Clinical/Epidemiology)